Paul Nguyen, MD

Brigham and Women's Hospital

Disclosure:
Employment
Dana-Farber/Brigham and Women's Cancer Center: Director of Prostate Brachytherapy/Associate Professor of Radiation Oncology: Employee

Compensation
Astellas: Research Grants; Augmenix: Consultant; Ferring: Consultant; Genome DX: Advisory Board; Janssen: Research Grants; Nanobiotix: Consultant

Ownership
Augmenix: Stock Options

Leadership
Genitourinary Cancers Symposium: Program Committee Chair

Presentation(s):

• Prostate: LBA5 - Short Term Androgen Deprivation Therapy Without or With Pelvic Lymph Node Treatment Added to Prostate Bed Only Salvage Radiotherapy: The NRG Oncology/RTOG 0534 SPPORT Trial

  Saturday, October 20
  5:19 PM – 5:31 PM

• SS 11 - HSR 1

  Monday, October 22
  7:45 AM – 9:00 AM

• 202 - Genomic Validation of Three-Tiered Sub-Classification of High-Risk Prostate Cancer

  Tuesday, October 23
  3:15 PM – 3:25 PM